Oppenheimer & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.4M | Buy |
254,090
+15,473
| +6% | +$902K | 0.19% | 111 |
|
|
2025
Q4 | $12.9M | Sell |
238,617
-7,180
| -3% | -$345K | 0.18% | 117 |
|
|
2025
Q3 | $11.1M | Buy |
245,797
+2,091
| +0.9% | +$97.7K | 0.14% | 163 |
|
|
2025
Q2 | $11.3M | Buy |
243,706
+1,197
| +0.5% | +$58.8K | 0.15% | 152 |
|
|
2025
Q1 | $14.8M | Buy |
242,509
+27,289
| +13% | +$1.59M | 0.22% | 86 |
|
|
2024
Q4 | $12.2M | Sell |
215,220
-18,991
| -8% | -$1.06M | 0.18% | 109 |
|
|
2024
Q3 | $12.1M | Buy |
234,211
+30,872
| +15% | +$1.45M | 0.18% | 107 |
|
|
2024
Q2 | $8.44M | Sell |
203,339
-15,510
| -7% | -$694K | 0.13% | 164 |
|
|
2024
Q1 | $11.9M | Buy |
218,849
+26,519
| +14% | +$1.35M | 0.2% | 112 |
|
|
2023
Q4 | $9.87M | Sell |
192,330
-15,254
| -7% | -$801K | 0.18% | 122 |
|
|
2023
Q3 | $12M | Sell |
207,584
-24,621
| -11% | -$1.51M | 0.25% | 80 |
|
|
2023
Q2 | $14.8M | Sell |
232,205
-2,759
| -1% | -$185K | 0.3% | 70 |
|
|
2023
Q1 | $16.3M | Buy |
234,964
+1,720
| +0.7% | +$121K | 0.35% | 59 |
|
|
2022
Q4 | $16.8M | Sell |
233,244
-10,412
| -4% | -$785K | 0.38% | 49 |
|
|
2022
Q3 | $17.3M | Sell |
243,656
-20,135
| -8% | -$1.46M | 0.41% | 45 |
|
|
2022
Q2 | $20.3M | Sell |
263,791
-14,949
| -5% | -$1.14M | 0.44% | 40 |
|
|
2022
Q1 | $20.4M | Buy |
278,740
+9,871
| +4% | +$663K | 0.37% | 48 |
|
|
2021
Q4 | $16.8M | Sell |
268,869
-25,204
| -9% | -$1.48M | 0.29% | 67 |
|
|
2021
Q3 | $17.4M | Buy |
294,073
+13,057
| +5% | +$860K | 0.33% | 58 |
|
|
2021
Q2 | $18.8M | Sell |
281,016
-91,557
| -25% | -$5.97M | 0.34% | 56 |
|
|
2021
Q1 | $23.5M | Sell |
372,573
-13,343
| -3% | -$830K | 0.47% | 30 |
|
|
2020
Q4 | $23.9M | Buy |
385,916
+13,440
| +4% | +$826K | 0.51% | 30 |
|
|
2020
Q3 | $22.5M | Buy |
372,476
+6,720
| +2% | +$404K | 0.56% | 28 |
|
|
2020
Q2 | $21.5M | Sell |
365,756
-12,325
| -3% | -$737K | 0.56% | 34 |
|
|
2020
Q1 | $21.1M | Buy |
378,081
+14,026
| +4% | +$857K | 0.64% | 28 |
|
|
2019
Q4 | $23.4M | Buy |
364,055
+62,958
| +21% | +$3.61M | 0.58% | 32 |
|
|
2019
Q3 | $15.3M | Sell |
301,097
-3,192
| -1% | -$150K | 0.42% | 51 |
|
|
2019
Q2 | $13.8M | Buy |
304,289
+6,298
| +2% | +$293K | 0.38% | 56 |
|
|
2019
Q1 | $14.2M | Sell |
297,991
-8,212
| -3% | -$409K | 0.38% | 55 |
|
|
2018
Q4 | $15.9M | Sell |
306,203
-35,746
| -10% | -$1.92M | 0.5% | 43 |
|
|
2018
Q3 | $21.2M | Sell |
341,949
-569
| -0.2% | -$33.8K | 0.54% | 36 |
|
|
2018
Q2 | $19M | Sell |
342,518
-2,437
| -0.7% | -$132K | 0.51% | 40 |
|
|
2018
Q1 | $21.8M | Buy |
344,955
+2,050
| +0.6% | +$132K | 0.56% | 30 |
|
|
2017
Q4 | $21M | Sell |
342,905
-2,633
| -0.8% | -$165K | 0.54% | 34 |
|
|
2017
Q3 | $22M | Sell |
345,538
-12,971
| -4% | -$757K | 0.59% | 27 |
|
|
2017
Q2 | $20M | Buy |
358,509
+8,813
| +3% | +$480K | 0.55% | 26 |
|
|
2017
Q1 | $19M | Sell |
349,696
-1,995
| -0.6% | -$109K | 0.54% | 31 |
|
|
2016
Q4 | $20.6M | Sell |
351,691
-11,339
| -3% | -$620K | 0.6% | 26 |
|
|
2016
Q3 | $19.6M | Buy |
363,030
+104,669
| +41% | +$6.72M | 0.57% | 28 |
|
|
2016
Q2 | $19M | Sell |
258,361
-20,642
| -7% | -$1.46M | 0.57% | 27 |
|
|
2016
Q1 | $17.8M | Sell |
279,003
-4,621
| -2% | -$291K | 0.54% | 33 |
|
|
2015
Q4 | $19.5M | Buy |
283,624
+6,518
| +2% | +$431K | 0.58% | 29 |
|
|
2015
Q3 | $16.4M | Sell |
277,106
-19,144
| -6% | -$1.21M | 0.5% | 37 |
|
|
2015
Q2 | $19.7M | Buy |
296,250
+5,582
| +2% | +$368K | 0.55% | 28 |
|
|
2015
Q1 | $18.7M | Buy |
290,668
+5,646
| +2% | +$353K | 0.51% | 37 |
|
|
2014
Q4 | $16.8M | Sell |
285,022
-27,392
| -9% | -$1.54M | 0.48% | 39 |
|
|
2014
Q3 | $16M | Sell |
312,414
-37,634
| -11% | -$1.88M | 0.48% | 35 |
|
|
2014
Q2 | $17M | Sell |
350,048
-22,022
| -6% | -$1.09M | 0.51% | 32 |
|
|
2014
Q1 | $19.3M | Buy |
372,070
+47,478
| +15% | +$2.53M | 0.58% | 26 |
|
|
2013
Q4 | $17.3M | Sell |
324,592
-29,855
| -8% | -$1.52M | 0.55% | 30 |
|
|
2013
Q3 | $16.4M | Buy |
354,447
+36,437
| +11% | +$1.6M | 0.58% | 29 |
|
|
2013
Q2 | $14.2M | Buy |
+318,010
| New | +$13.8M | 0.55% | 30 |
|
Other funds holding BMY
VCM
VPM
Oppenheimer & Co's BMY Position: Q1 2026 in Review
Oppenheimer & Co increased its Bristol-Myers Squibb (BMY) stake by 6.5% in Q1 2026, buying an estimated $902K and bringing the position to 254,090 shares worth $15.4M. The position accounts for 0.19% of the portfolio, ranked #111.
Oppenheimer & Co first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.9M in Q4 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Oppenheimer & Co held 254,090 shares of Bristol-Myers Squibb worth $15.4M as of Q1 2026.
- Oppenheimer & Co bought 15,473 Bristol-Myers Squibb shares in Q1 2026, an estimated $902K.
- Bristol-Myers Squibb made up 0.19% of Oppenheimer & Co's portfolio in Q1 2026, its #111 holding.
- Oppenheimer & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's Bristol-Myers Squibb position peaked at $23.9M in Q4 2020.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.